Key result
Defects in the connective tissue protein fibrillin, caused by mutations in the fibrillin gene, are the molecular basis of Marfan syndrome.
The discovery that mutations in the fibrillin gene cause Marfan syndrome provides the molecular basis for understanding this inherited cardiovascular disorder.
Answers are grounded in this paper and cite their sources.
Facilitates targeted genetic testing in suspected Marfan cases; leaves open modifier effects on phenotypic severity.
The Marfan syndrome is an inherited, autosomal dominant disorder that affects the skeletal, ocular, and cardiovascular systems. Recent biochemical and genetic studies have demonstrated that this deadly genetic disorder arises from defects in the connective tissue protein fibrillin. Fibrillin is a component of microfibrils, structures found in the extracellular matrices of most tissues, including those affected in Marfan patients. The appearance of microfibrils in the matrix produced by Marfan patient fibroblasts is different from that of normal cells. Genetic linkage between the fibrillin gene and the Marfan phenotype has been established and the gene mapped to the same chromosomal position as the disease locus. In several instances, the disease has been associated with mutations in the fibrillin gene, confirming that defects in fibrillin cause the Marfan syndrome.
No takes yet. Share an insight, caveat, or question.
Maslen et al. (1993) conducted a review in Marfan syndrome. Fibrillin gene mutations was evaluated. Defects in the connective tissue protein fibrillin, caused by mutations in the fibrillin gene, are the molecular basis of Marfan syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: